![PRD_000272 PRD_000272](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000272.svg) | PRD_000272 | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | Formula: | C34 H50 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000275 PRD_000275](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000275.svg) | PRD_000275 | Name: | Ac-DADE-F(2)Pmp-L-NH(2) | Formula: | C32 H46 F2 N7 O15 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000276 PRD_000276](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000276.svg) | PRD_000276 | Name: | Thrombostatin FM inhibitor [rOicPaF(p-Me)] | Formula: | C33 H52 N9 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001055 PRD_001055](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/K95.svg) | PRD_001055 | Name: | (4R)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-3-[(2S,3S)-2-hydroxy-3-{[S-methyl-N-(phenylacetyl)-L-cysteinyl]ami
no}-4-phenylbutanoyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide | Formula: | C37 H44 N4 O6 S2 | Definition date: | 2012-12-12 | Last modified: | 2013-08-26 |
|
![PRD_000277 PRD_000277](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000277.svg) | PRD_000277 | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]-L-valinamide | Formula: | C27 H35 Cl N4 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001057 PRD_001057](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001057.svg) | PRD_001057 | Name: | ACETYL-PEPSTATIN | Formula: | C31 H57 N5 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000278 PRD_000278](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000278.svg) | PRD_000278 | Name: | DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE | Formula: | C34 H71 Cl N11 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001058 PRD_001058](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/EEG.svg) | PRD_001058 | Name: | N-{3-[4-(4-phenylthiophen-2-yl)phenyl]propanoyl}-L-alpha-glutamyl-L-alpha-glutamyl-amide | Formula: | C29 H31 N3 O7 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000279 PRD_000279](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0FG.svg) | PRD_000279 | Name: | D-leucyl-N-(4-fluorobenzyl)-L-phenylalaninamide | Formula: | C22 H28 F N3 O2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000280 PRD_000280](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000280.svg) | PRD_000280 | Name: | HIV ENTRY INHIBITOR PIE1 | Formula: | C80 H118 N22 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001060 PRD_001060](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/QEG.svg) | PRD_001060 | Name: | N~2~-{3-[4-(4-phenylthiophen-2-yl)phenyl]propanoyl}-L-glutaminyl-L-alpha-glutamine | Formula: | C29 H32 N4 O6 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000281 PRD_000281](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000281.svg) | PRD_000281 | Name: | HIV ENTRY INHIBITOR PIE7 | Formula: | C81 H110 N20 O22 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000282 PRD_000282](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000282.svg) | PRD_000282 | Name: | N-acetyl-L-alpha-aspartyl-L-asparaginyl-N-[(1R)-2-carboxy-1-formylethyl]-L-leucinamide | Formula: | C20 H33 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000283 PRD_000283](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0FP.svg) | PRD_000283 | Name: | N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-{[(1R)-1-phenylpropyl]amino}butan-2-yl]-N~4~,N~4~-dimethyl-L-aspartamide | Formula: | C37 H63 N7 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000284 PRD_000284](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000284.svg) | PRD_000284 | Name: | AC-DQMD-CHO | Formula: | C20 H33 N5 O10 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000285 PRD_000285](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000285.svg) | PRD_000285 | Name: | L-tryptophyl-L-tyrosyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-threoninamide | Formula: | C31 H44 Cl N8 O6 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000286 PRD_000286](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000286.svg) | PRD_000286 | Name: | D-valyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-L-leucinamide | Formula: | C18 H36 Cl N4 O3 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000287 PRD_000287](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0GE.svg) | PRD_000287 | Name: | N-{[5-(dimethylamino)naphthalen-1-yl]sulfonyl}-L-alpha-glutamyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]glycinamide | Formula: | C26 H38 Cl N7 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001069 PRD_001069](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001069.svg) | PRD_001069 | Name: | N-acetyl-L-alanyl-L-alanyl-N-[(2S)-1-hydroxypropan-2-yl]-L-prolinamide | Formula: | C16 H28 N4 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000288 PRD_000288](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0GJ.svg) | PRD_000288 | Name: | L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide | Formula: | C14 H28 Cl N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000289 PRD_000289](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000289.svg) | PRD_000289 | Name: | BETA-SECRETASE INHIBITOR OM00-3 | Formula: | C44 H69 N7 O15 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001071 PRD_001071](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/3SD.svg) | PRD_001071 | Name: | N~4~-(2,2-dimethylpropyl)-N~1~-{(2S)-1-[(4-methylbenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[(5-methyl-1,2-oxazol-3-yl)carbonyl]-L-aspartamide | Formula: | C32 H41 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000290 PRD_000290](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000290.svg) | PRD_000290 | Name: | BETA-SECRETASE INHIBITOR OM99-2 | Formula: | C41 H64 N8 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001072 PRD_001072](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001072.svg) | PRD_001072 | Name: | Thiocillin GE2270 analogue NVP-LFF571 | Formula: | C60 H72 N13 O13 S6 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000291 PRD_000291](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000291.svg) | PRD_000291 | Name: | BETA-SECRETASE INHIBITOR NVP-AUR200 | Formula: | C34 H61 N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|